Searchable abstracts of presentations at key conferences in endocrinology

ea0011p933 | Thyroid | ECE2006

Thyroid storm induced cardiomyopathy is reversible

Neary NM , Fountain AEC , Hatfield ECI , Fox KF , Meeran K

A 31-year-old Taiwanese lady presented with palpitations, anxiety, orthopnoea, peripheral oedema, diarrhoea and a swelling in her neck. She was taking no regular medication. Her paternal uncle had been treated for thyrotoxicosis. She smoked 20 cigarettes per day. Clinical examination revealed tachycardia (pulse rate between 115 and 150 beats/min), tachypnoea (respiratory rate 30 breaths/min), hypertension (BP 161/125 mmHg) and congestive cardiac failure. The thyroid gland was ...

ea0011p942 | Thyroid | ECE2006

Comparison of radioiodine with radioiodine plus lithium in the treatment of hyperthyroidism

Ahmed K , Nijher GMK , Banerjee A , Frank J , Meeran K

Introduction: Radioactive Iodine (RAI) is a well-established and effective treatment for hyperthyroidism. Lithium (Li) blocks the release of organic iodide and thyroid hormone from the thyroid gland without effecting thyroidal RAI uptake. Through decreasing the loss of RAI from the thyroid it has also been shown to reduce urinary RAI excretion. Its use as an adjunct to RAI in the therapy of hyperthyroidism has been postulated, but information on the subject is limited.<p c...

ea0010p53 | Pituitary | SFE2005

Is screening for colonic cancer in acromegaly fruitful?

Wujanto C , Jayasena C , Banerjee A , Meeran K , Todd J

Background: Controversy exists over the prevalence of colonic neoplasia in individuals with acromegaly. Some previous studies have demonstrated an increased prevalence of colorectal neoplasia compared to controls, however others have shown no such association. Furthermore, colonoscopy in acromegalic individuals has an increased rate of complications and even death....

ea0010p54 | Pituitary | SFE2005

Long-term review of 21 acromegalic patients with yttrium-90 implants

Jayasena C , Wujanto C , Todd J , Meeran K

Background: Yttrium-90 (90Y) pituitary implants have previously been used to treat patients with growth hormone (GH) secreting pituitary adenoma. This study reports the long-term effect of 90Y implants on growth hormone levels and pituitary function in a group of acromegalic patients....

ea0010p55 | Pituitary | SFE2005

Challenges of colonoscopy in patients with acromegaly

Wujanto C , Jayasena C , Todd J , Meeran K

BackgroundPrevious studies suggest that patients with acromegaly should have regular colonoscopic examinations due to their increased risk of colorectal neoplasia. However, acromegalic patients have significantly enlarged colon and increased rate of complications due to colonoscopy have been reported.AimTo assess the difficulty of performing colonoscopy in acromegalic patients by comparing large bowel length,...

ea0010p96 | Thyroid | SFE2005

Comparison of radioiodine with radioiodine plus lithium in the treatment of hyperthyroidism

Ahmed K , Nijher G , Bannerjee A , Frank J , Meeran K

Introduction: Radioactive Iodine (RAI) is a well-established and effective treatment for hyperthyroidism. Lithium (Li) blocks the release of organic iodide and thyroid hormone from the thyroid gland without effecting thyroidal RAI uptake. Through decreasing the loss of RAI from the thyroid it has also been shown to reduce urinary RAI excretion. Its use as an adjunct to RAI in the therapy of hyperthyroidism has been postulated, but information on the subject is limited....

ea0009p123 | Endocrine tumours and neoplasia | BES2005

Screening and prevalence of endocrine and radiological pituitary abnormalities in adult-onset Langerhans cell histiocytosis

Jayasena C , Lewis D , Chu A , Meeran K , Devendra D

Adult-onset Langerhans Cell Histiocytosis (LCH) is a rare disease characterised by the abnormal proliferation of Langerhans cells, and has a distinct phenotype to that of childhood-onset LCH. Diabetes Insipidus (DI) is a well-recognised manifestation of LCH, caused by infiltration of the hypothalamo-pituitary axis (HPA). Anterior pituitary dysfunction is an uncommon complication of LCH, which has been shown to be associated with DI. However, this association has previously onl...

ea0008p45 | Endocrine Tumours and Neoplasia | SFE2004

Diagnosis of a gastrinoma in patients on proton pump inhibitor therapy

Lewis CJ , Dhillo WS , Meeran K , Todd JF

BACKGROUND: Patients with dyspepsia are treated with proton pump inhibitors (PPIs) which reduce acid secretion and therefore give rise to a secondary hypergastrinaemia. Gastrinomas are a rare cause of dyspepsia diagnosed on the basis of a raised fasting gastrin measurement. Therefore, when screening patients with dyspepsia for a gastrinoma, PPIs must be withdrawn for 2 weeks, prior to the measurement of fasting gastrin levels to ensure that fasting gastrin levels are back to b...

ea0007p76 | Endocrine tumours and neoplasia | BES2004

Galectin-3 staining of benign and malignant thyroid lesions - is it a useful diagnostic tool?

Davies R , Barakat M , Meeran K , Dina R

Background:Galectin-3, a beta-galactosidase binding lectin, has been reported to be preferentially expressed in thyroid malignancies by many authors. Moreover, it has been claimed that galectin-3 is a useful adjunct to fine-needle aspiration (FNA) in the diagnosis of follicular thyroid lesions, a notorious pitfall of this test. Although galectin-3 does seem to be expressed more often in malignant thyroid lesions, especially papillary carcinomas, it is fr...

ea0007p234 | Thyroid | BES2004

Adjunctive lithium improves outcome in patients given radioiodine for hyperthyroidism

Murphy E , Winstanley G , Frank J , Meeran K

Lithium blocks the release of organic iodine and thyroid hormone from the thyroid gland without affecting thyroidal radioactive iodine (RAI) uptake. From August 2001, we have been using lithium carbonate 800mg nocte as an adjunct to RAI treatment for thyrotoxicosis. Antithyroid medication is stopped and lithium started 3 days before RAI. Lithium is continued for 10 days in total with levels checked at 3 and 10 days. Thyroid function tests (TFTs) are measured 1, 3, 6, 9 and 12 ...